Introduction
The proliferation of many hematopoietic precursor cells is promoted by interleukin-3 (IL-3), granulocyte/ macrophage-colony stimulating factor (GM-CSF), stem cell factor (SCF),¯t-3L (the ligand for the tyrosine kinase receptors¯t-2 and¯t-3), thrombopoietin and certain other cytokines (Arai et al., 1990; Wang and McCubrey, 1997a; Blalock et al., 1999) . Hematopoietic cell lines have been isolated which require IL-3 or in some cases GM-CSF for survival and cell proliferation (Dexter et al., 1980; McKearn et al., 1985; Kitamura et al., 1989) . The human TF-1 cell line is a cytokine-dependent (IL-3, GM-CSF) line that was isolated from a patient with erythroleukemia (Kitamura et al., 1989) . FDC-P1 is an IL-3/GM-CSFdependent cell line recovered from the bone marrow of a DBA/2 mouse (Dexter et al., 1980) , and FL5.12 is an IL-3 dependent cell line isolated from murine fetal liver (McKearn et al., 1985) . All of these cell lines are representative of early hematopoietic precursor cells (McCubrey et al., 1989; Wang and McCubrey, 1997a; Wang et al., 1997) . Cytokine-deprivation of these cells results in rapid cessation of growth with subsequent death by apoptosis, (programmed cell death) (McCubrey et al., 1989 Wang and McCubrey, 1997a; Blalock et al., 1999) . In the presence of the appropriate cytokine, these cells proliferate continuously, however, they are non-tumorigenic when injected into immunocompromised mice (Kitamura et al., 1989; McCubrey et al., 1989 McCubrey et al., , 1993 Mayo et al., 1995; McCubrey, 1996, 1997b) . Spontaneous factor-independent cells are rarely recovered from FDC-P1 and FL5.12 cell lines which makes them attractive models to analyse the eects that various genes have on signal transduction and leukemogenesis, since abrogation of cytokine-dependency may be an important factor in the development of leukemia (McCubrey et al., 1989 (McCubrey et al., , 1991 Mayo et al., 1995; McCubrey, 1996, 1997b; Wang et al.,1998) .
IL-3 and GM-CSF exert their biological activity by binding to the IL-3 and GM-CSF receptors respectively. These receptors are comprised of a ligandspeci®c a-subunit and a common b-subunit (b c ) which is essential for signal transduction (Kitamura et al., 1991; Miyajima et al., 1992; Algate et al., 1994; Ihle et al., 1995; Kinoshita et al., 1995; Steelman et al., 1996; Blalock et al., 1999) . The binding of these cytokines to their cognate receptors activates Janus (Jak) protein tyrosine kinases which lead to the phosphorylation and dimerization of signal transducers and activators of transcription (STAT). Activated STAT proteins then regulate the expression of key genes involved in cell growth (Ihle et al., 1995; Yoshimura, 1998; Blalock et al., 1999) . The activation of Jak-2 by IL-3 may occur by receptor aggregation resulting in the multimerization of associated Jak-2 proteins (Ihle et al., 1995) . Upon receptor ligation, a complex, consisting of Cbl/ Grb2/Sos and the guanidine nucleotide-exchange factor Vav, is recruited to the b c chain by tyrosine phosphorylated Shc (Oadi et al., 1995 (Oadi et al., , 1997a Hanazono et al., 1996) . The receptor associated complex results in the stimulation of Ras as well as additional signal transduction molecules such as PI 3 kinase and potentially members of the Src-family of tyrosine kinases (Anderson et al., 1997; Mufson, 1997) . Activated Ras promotes the sequential activation of Raf, MEK and MAP kinases (Dent et al., 1993 (Dent et al., , 1994 (Dent et al., , 1995 Jelinek et al., 1996) . Recently, it was shown that Jak1 can directly activate Raf indicating cross-talk capability between these two signal transduction pathways (Stancato et al., 1997 Sakatsume et al., 1998) . Evidence suggests that the Ras/Raf/MEK/ MAPK pathway is intimately associated with the control of cell growth, dierentiation and apoptotic machinery in myelo-monocytic cells (Kinoshita et al., 1995; Mufson, 1997; Herrera et al., 1998; Shelly et al., 1998; Dent et al., 1998) .
Constitutively-activated forms of MEK1 have been described that transform NIH3T3 cells. Either deletion of the N-terminal negative regulatory domain, which contains the nuclear export signal (NES), or substitution of serine with aspartic acid and/or glutamic acid at two critical phosphorylation sites results in an activated MEK1 oncoprotein (Cowley et al., 1994; Mansour et al., 1994; Huang et al., 1994; Brunet et al., 1994) . MEK1 expression can lead to activation of the MAP kinases, ERK1 and ERK2. These protein kinases have pleotropic eects on the cell but likely elicit some of their eects by the phosphorylation of transcription factors that control gene expression Dent et al., 1998) .
Abrogation of cytokine-dependency requires the prevention of apoptosis. Hence, in addition to promoting cell cycle progression, cytokines must aect the machinery that controls cell survival. Apoptosis is strongly in¯uenced by the activity of Bcl-2 and its family members (Gajewski and Thompson, 1996; Yang et al., 1995; Wang et al., 1994 Wang et al., , 1996a Zha et al., 1996) . Both Bcl-2 and Bcl-x L promote cell survival whereas Bax and Bad promote cell death (Gajewski and Thompson, 1996; Yang et al., 1995) . Although the precise details of how cytokines in¯uence the function of these proteins are not fully elucidated, recent evidence has suggested that protein expression, subcellular localization and phosphorylation leading to the control of protein ± protein interactions may be central to the process (May et al., 1994; Wang et al., 1994 Wang et al., , 1996a Rinaudo et al., 1995; Zha et al., 1996; del Peso et al., 1997; Ito et al., 1997; Deng et al., 1998; Gubina et al., 1998) . Moreover, the Ras/Raf/MEK/ ERK kinase pathway can suppress apoptosis in cytokine-dependent cells (Wang et al., 1994; Cleveland et al., 1994; Kinoshita et al., 1995) . The role(s) of MEK1 in the apoptotic pathways is not clear. However, some studies with PC 12 neuronal cells have shown that c-Jun N-terminal Kinase (JNK) and MEK1 have opposing eects on apoptosis with JNK promoting and MEK1 inhibiting programmed cell death (Xia et al., 1995) .
It has been reported that activated MEK1 failed to relieve the IL-3-dependency of the BAF/3 cell line (Perkins et al., 1996) . However, given the pivotal role of MEK1 in the MAP kinase cascade, we decided to investigate the ability of activated MEK1 to abrogate the cytokine-dependency of other cytokine-dependent human and murine cell lines. In this study, the eects a conditionally-active form of MEK1 had on the cytokine-dependency of TF-1, FDC-P1 and FL5.12 hematopoietic cells were examined. We demonstrate the ability of activated MEK1 to convert a subset of TF-1, FDC-P1 and FL5.12 cells to a cytokineindependent phenotype. DMEK1:ER induced ERK2 activity with higher levels detected in estradiolresponsive as compared to cytokine-dependent DME-K1:ER-infected cells. In addition, DMEK1:ER induced GM-CSF mRNA accumulation which may contribute to an autocrine proliferate loop in these cells. Understanding the molecular mechanisms of these eects will further our comprehension of the role the MEK/MAP kinase pathway plays in the control of both normal and aberrant cell proliferation.
Results

Aberrant MEK1 activation can abrogate the cytokine-dependency of hematopoietic cells
It was shown previously that constitutively-active forms of MEK1 can transform NIH3T3 and Chinese hamster ovary (CHO) ®broblast cells in culture (Cowley et al., 1994; Mansour et al., 1994; Huang et al., 1994; Brunet et al., 1994) . We wished to determine the eects of a conditionally-active form of MEK1 on cells that require the presence of cytokines for proliferation. The following studies have utilized a conditionallyactive form of MEK1 generated by the fusion of sequences encoding a constitutively-active form of MEK1 (DN3-S218E-S222D) to the hormone-binding domain of the human estrogen-receptor in a manner analogous to that described previously for Raf (Samuels et al., 1993; Pritchard et al., 1995; Bosch et al., 1997; McCubrey et al., 1998; Aziz et al., 1999) .
TF-1 cells were infected with a retrovirus encoding DMEK1:ER or an empty vector encoding only puromycin resistance (puro r ). Infected cells were subsequently selected in growth medium containing puromycin in the presence of either GM-CSF or bestradiol. Pools of puro r TF-1 cells were recovered from both selection conditions and expanded from 96-well plates after approximately 2 weeks in culture. Thus, infection with the DMEK1:ER encoding retrovirus allowed some TF-1 cells to grow in medium lacking exogenous GM-CSF. While empty retroviral vector infected puro r cells were recovered in medium containing GM-CSF and puromycin, no empty retroviral vector infected cells were recovered in medium containing b-estradiol and puromycin. In addition, no colonies were obtained from mock-infected TF-1 cells cultured under either selection condition. Thus, an activated MEK1 gene was necessary to abrogate the cytokinedependency of TF-1 cells.
To determine the eciency of abrogation of cytokine-dependency of TF-1 cells by the DMEK1:ER oncoprotein, limiting dilution analysis was performed. When the TF/DMEK1:ER pool of cells, which had been isolated in GM-CSF and puromycin [TF/ DMEK1:ER(GM)pool], was cultured in the presence of GM-CSF, a plating eciency of approximately 1 was observed, i.e., every cell gave rise to a clone. In contrast, when the cells were cultured in the absence of GM-CSF but in the presence of b-estradiol, approximately one in 400 cells gave rise to a clone (an eciency of 2.5610 73 ) (Table 1) . Thus, there was a 400-fold dierence in the plating eciency of the cells in GM-CSF vs b-estradiol. Similar experiments were performed with the empty-vector pBabepuro-infected TF-1 cells; however, no cytokine-independent cells were recovered upon limiting dilution analysis of these empty-vector-infected cells (Table 1) (Table 1) . When a pool of empty-vector pBabepuro3-infected FDC-P1 cells was plated in bestradiol, in the absence of IL-3, no estradiolresponsive cells were isolated (Table 1) .
Finally, the eects of DMEK1:ER expression on the cytokine-dependency of FL5.12 cells were examined. After limiting dilution analysis of the pools selected in IL-3 and puromycin (n=four pools), each cell could give rise to a colony in the presence of IL-3, but only one in 10 7 DMEK-1:ER-infected FL5.12 cells would grow in medium containing b-estradiol (an eciency of 1610 77 ) ( Table 1 ). In contrast, no cytokine-independent FL5.12 cells were recovered after infection with the empty retroviral vector (Table 1) . Thus, these dierent hematopoietic cells varied in their ability to be transformed to cytokine-independence by an oncogenic form of MEK1.
Responsiveness of TF/DMEK1:ER cells to b-estradiol
The growth characteristics of the TF/DMEK1:ER pools which had been isolated in puromycin and either GM-CSF or b-estradiol were compared ( Figure 1 ). The TF/DMEK1:ER(GM) pool, grew in response to GM-CSF but not b-estradiol ( Figure 1a ). Similar results were observed with four TF/DMEK1:ER(GM) clones which were isolated after limiting dilution experiments in the presence of exogenous GM-CSF (data not presented). In contrast, the TF/DMEK1:ER(Est) pool proliferated in response to both GM-CSF and bestradiol ( Figure 1b ). Neither cell line grew in the absence of exogenous GM-CSF or b-estradiol indicating that the cells had not acquired cytokine-independence as a result of an unrelated genetic event.
In order to measure DNA synthesis induced in response to either GM-CSF or activation of DME-K1:ER, the pooled populations described above were treated with dierent concentrations of GM-CSF or bestradiol for 3 days and then pulsed with Figure 1c ). These cells also showed a modest response to b-estradiol that was not seen with the parental uninfected population ( Figure 1e and data not shown). Individual clones selected in GM-CSF and puromycin also showed a similar response to b-estradiol (data not shown).
TF/DMEK1:ER(Est) cells responded to both GM-CSF and b-estradiol (Figure 1d ,f). The peak response was observed at GM-CSF concentrations of 100 pg/ml ]thymidine incorporation was observed with b-estradiol in concentrations greater than 15 nM. In summary, DMEK1:ER activation, as well as GM-CSF, was able to promote DNA synthesis and growth in the TF/DMEK1:ER(Est) cells.
Growth characteristics of DMEK1:ER-infected FDC-P1 and FL5.12 cells
The growth properties of DMEK1:ER-infected FDC-P1 clones were compared. Fourteen FD/DMEK1:ER-(IL3) clones that were isolated in IL-3 and six FD/ DMEK1:ER(Est) clones that were isolated in bestradiol were examined (Figure 2 ). The IL-3 selected clones fell in two classes as represented by FD/ DMEK1:ER(IL3)c1 (n=4) and FD/DMEK1:ER-(IL3)c2 (n=10). The growth of all the DMEK1:ERresponsive cells was similar to that represented by FD/ DMEK1:ER(Est)c1.
As expected, all clones grew ( 
Requirement for functional MEK1 activity for proliferation
The ability of the MEK1 inhibitor to suppress cell proliferation was also examined in the FD/DMEK1:ER ( Figure 4a ) and TF/DMEK1:ER cells (Figure 4b ). The MEK1 inhibitor suppressed the estradiol-responsive growth of these cells as they died upon treatment with PD98059. In addition, the MEK1 inhibitor suppressed DMEK1:ER-induced [ MEK activity was also detected at higher levels in TF/DMEK1:ER(GM)c1 and c4 cells (Figure 5d ,e) when they were cultured in b-estradiol and GM-CSF (lanes 3) or in b-estradiol (lanes 4) as opposed to no supplement (lanes 1) or GM-CSF (lanes 2) indicating that b-estradiol induced DMEK1:ER activity. Likewise, higher levels of DMEK1:ER activity were detected in the TF/DMEK1:ER(Est) cells (Figure 5f ) when they were cultured in either b-estradiol and GM-CSF (lane 3) or b-estradiol (lane 4) than when they were cultured in the absence of GM-CSF and b-estradiol (lane 1) or with GM-CSF (lane 2). Similar results were seen with FL/DMEK1:ER cells (data not presented).
In order to compare the kinetics of IL-3 and bestradiol induced DMEK1:ER activation in DME-K1:ER-infected cells, time course assays were performed on both estradiol-responsive and estradiol-nonresponsive FD/DMEK1:ER cells ( Figure 6 ). As a control, the level of endogenous MEK1 activity in uninfected FDC-P1 cells was examined. IL-3 resulted in the stimulation of MEK1 activity as early as 1 min after addition with activity reaching a maximum after approximately 1 h and a secondary activation at later time points (8 ± 24 h). PMA, which was used as a control with the parental FDC-P1 cells, resulted in a potent activation of endogenous MEK1 which peaked after 15 min and remained relatively high for approximately 1 h (Figure 6a (Figure 6c ) cells dropped to near basal levels after 1 h but quickly rose again at 4 h and remained elevated for up to 12 h. These results suggest an alteration in the signal transduction activity, in cytokine-independent FD/ DMEK1:ER cells as opposed to cytokine-dependent FD/DMEK1:ER cells, occurring between 1 and 4 h after stimulation with b-estradiol.
MEK1 activates p42 MAPK in DMEK1:ER-infected hematopoietic cells
Two of the downstream substrates of MEK1 are the MAP kinases (ERK1 and ERK2). The ability of DMEK1:ER to activate ERK2 was examined in cytokine-dependent and cytokine-independent FD/ DMEK1:ER, FL/DMEK1:ER and TF/DMEK1:ER cells. Prior to treatment, the cells were deprived of cytokine for 24 h and then treated with cytokine, bestradiol or, in some cases, PMA. In all cells examined, cytokine and PMA lead to the rapid activation (15 ± 30 min) of ERK2 (Figure 7) . In contrast, not all the cells examined had increased ERK2 activity in response to b-estradiol. Parental cell controls (FDC-P1, FL5.12 and TF-1) (Figure 7a,d and data not shown) displayed very low ERK2 activity in response to b-estradiol.
In contrast, the cytokine-dependent cells, FD/ DMEK1:ER(IL3)c2, FL/DMEK1:ER(IL3) pool and , showed increased ERK2 activity in response to b-estradiol. ERK2 activation in response to bestradiol was slightly augmented in these cells with initial activity appearing as early as 1 min and a prolonged activity appearing approximately 2 ± 4 h after treatment and lasting up to 12 ± 24 h. These results indicate that activation of DMEK1:ER can result in MAP kinase activation and suggest the possibility of an autocrine stimulatory loop.
Autocrine GM-CSF expression in DMEK1:ER-responsive cells
To examine whether MEK1 induced an autocrine growth component, the presence of autocrine cytokine expression was examined in the cytokine-dependent and DMEK1:ER-responsive cells by reverse transcriptase PCR (RT ± PCR). GM-CSF cDNAs were observed in the DMEK1:ER-responsive FD/DMEK1:ER, FL/ DMEK1:ER and TF/DMEK1:ER cells but were not observed in the cells which remained cytokinedependent ( Figure 8a and data not presented). These cDNAs were veri®ed as GM-CSF by Southern blotting and use of a full-length GM-CSF probe (data not shown). Thus a consequence to growth in response to activated MEK1 was the synthesis of autocrine cytokine.
To determine the importance of this autocrine GM-CSF expression, the ability of this GM-CSF expression to promote [ (Figure 8b,c) . The signi®cance of the autocrine growth factor expression was further examined in the TF-1 cell system because these cells expressed higher levels of GM-CSF mRNA transcripts. The level of GM-CSF produced by the TF/DMEK1:ER(Est) cells was found to be sucient to promote the growth of parental TF-1 cells (Figure 8d) . In neutralizing studies, use of an a-GM-CSF monoclonal antibody (mAb) inhibited the incorporation of [ 
Discussion
One of the goals of this study was to investigate the eects of deregulated MEK1 activity on the cytokinedependency of hematopoietic cells. Using a conditional form of the MEK1 protein (DMEK1:ER), we were able to isolate TF-1, FDC-P1, and FL5.12 cells in which the requirement for exogenous cytokines was replaced by the activation of DMEK1:ER. Two dierent types of cells were recovered after infection with the DME-K1:ER retrovirus, cells which expressed DMEK1:ER and remained cytokine-dependent and cells which expressed DMEK1:ER and grew in response to bestradiol. The former cells were recovered 400-to 10 7 -fold more frequently than the latter cells depending upon the particular cell line examined. Aberrant DMEK1:ER expression did not readily abrogate cytokine-dependency of the FL5.12 cell line. It should be noted that both the FL5.12 cell line and the BAF/3 cell line were derived at the Basal Institute from similar mice and isolation conditions. Our results with DMEK1:ER and FL5.12 cells are similar to those published by Perkins et al. (1996) with BAF/3 cells. The reasons responsible for the dierences in recovery of MEK1-responsive cells from the FDC-P1, FL5.12 and TF-1 cell lines are unknown. These cell lines may dier in the expression of growth regulatory proteins which allow certain lines to become more readily transformed to cytokine-independent by DMEK1:ER than others. Alternatively, the TF-1 and FDC-P1 cell lines may be more prone to loosen tumor suppressor genes or other genes which permit them to grow in response to DMEK1:ER activation. Recent studies from our laboratory have indicated that FDC-P1 cells have a deleted p15 INK4 gene whereas this gene is still present in the FL5.12 cell line (data not shown). This could explain why DMEK1-responsive FDC-P1 cells were recovered 50-fold more frequent than DMEK1-responsive FL5.12 cells.
The DMEK1:ER oncoprotein was required for growth of the MEK1-responsive cells as the antiestrogen ICI and estrogen-receptor antagonist 4-HT stimulated [ 3 H]thymidine incorporation and growth, whereas these compounds did not induce proliferation in the uninfected parental cells. In addition, the MEK1 inhibitor PD98059 suppressed DMEK1:ER mediated [ 3 H]thymidine incorporation and growth of the MEK1-responsive cells. Dierent levels of MEK1 activity were detected in both DMEK1:ER-infected TF-1 and FDC-P1 cells (Figure 6 and data not presented). High levels of MEK activity were not sucient for estradiolresponsive growth, as the FD/DMEK1:ER(IL3)c2 and TF/DMEK1:ER(GM)c1 and c4 remained cytokinedependent ( Figure 6 and data not presented). However, cytokine-independent cells could be isolated more frequently from these cells, than from the cytokinedependent DMEK1:ER-infected cells which expressed lower levels of MEK activity (e.g., TF/DME-K1:ER(GM)c2 and FD/DMEK1:ER(IL3)c1, data not presented).
b-estradiol treatment of DMEK1:ER-infected cells lead to increased ERK2 activity in these cells. It will be relevant to determine which downstream targets of MEK1 are abnormally activated in cells which grow in response to DMEK1:ER. Further analysis of the DMEK1:ER-regulated intracellular signaling pathways (e) An aGM-CSF antibody was used to determine if it could block the autocrine eects mediated by bestradiol on the TF/DMEK1:ER(Est) pool. Symbols: &=anti-hGM-CSF antibody, *=anti-hIL-3 antibody and D=anti-hIGF antibody in these cells may provide clues to the nature of the dierences between responsive and non-responsive cells.
As was found in ®broblast models, aberrant activation of the Raf/MEK/MAPK pathway in hematopoietic cells resulted in the secretion of an autocrine growth factor (McCarthy et al., 1995; Kerkho and Rapp, 1997; McCubrey et al., 1998) . Cells that were MEK1-responsive were found to express GM-CSF mRNA transcripts. The level of GM-CSF secreted by these cells was sucient to promote the growth and survival of the parental cells. It is likely that the activation of DMEK1:ER in the MEK1-responsive cells and the subsequent activation of the MAP kinases, ERK1 and ERK2, result in the activation of transcription factors such as Elk-1 and CREB as well as the activation of additional pathways and transcription factors. These transcription factors may mediate the upregulation of GM-CSF transcription and possibly enhance GM-CSF mRNA stability.
These results suggest that there are relatively rare subsets of TF-1 and FDC-P1 cells which are susceptible to abrogation of cytokine-dependency by DMEK1:ER oncoproteins. Although these abrogation events may not occur in all hematopoietic cells lines, it is relevant to follow in the TF-1 and FDC-P1 lines, since abrogation of cytokine-dependency has been frequently linked to malignant transformation (McCubrey et al., 1989 (McCubrey et al., , 1993 Mayo et al., 1995; McCubrey, 1996, 1997b) .
Materials and methods
Cell lines and growth factors
Cells were maintained in a humidi®ed 5% CO 2 incubator. The human TF-1 line (Kitamura et al., 1989) was purchased from the ATCC (Rockville, MD, USA) and grown in Dulbecco's modi®ed Eagle's medium (DMEM, Life Technologies, Rockville, MD, USA) or RPMI 1640 (RPMI, Life Technologies) containing 5% fetal bovine serum (FBS, Atlanta Biologicals, Atlanta, GA, USA) supplemented with 1 ng/ml human rGM-CSF (R & D Systems, Minneapolis, MN, USA). The IL-3/GM-CSF-dependent murine myeloid cell line FDC-P1 (Dexter et al., 1980) and the IL-3 dependent lymphoid cell line FL5.12 (McKearn et al., 1985) were cultured in medium supplemented with 10% WEHI-3B(D 7 ) conditioned medium (WCM) as a source of murine IL-3, and 5% iron-supplemented bovine calf serum (BCS, Hyclone, Logan, UT, USA). Estradiol-dependent DMEK1:ER cells were grown in RPMI+5% FCS+1 mM b-estradiol (Sigma, St. Louis, MO, USA). DMEK1:ER-transformed cells were in some cases cultured in medium containing ICI 164 384 which binds and inhibits the function of the native estrogen-receptor but is an activator of the DMEK1:ER fusion protein (provided by Alan Wakeling, Zeneca Pharmaceuticals, Maccles®eld, UK). DMEK1:ER-infected cells were also cultured in 4-OH Tamoxifen (4-HT) (Research Biochemicals International, Natick, MA, USA), an estrogen analog which is also an activator of the DMEK1:ER fusion protein (Bosch et al., 1997) . DMEK1:ER-infected cells were in some cases treated with the MEK1-inhibitor PD98059 (Dudley et al., 1995) (New England Biolabs (NEB), Beverly, MA, USA), or the phorbol ester, phorbol 12-myristate 13-acetate (PMA) (Sigma). These chemicals were dissolved in either dimethyl sulfoxide (DMSO, Sigma) (PD98059 and PMA) or ethanol (ICI and 4-HT).
Assays of [ 3 H]thymidine incorporation
TF-1 cells were incubated for 3 days in the absence or presence of GM-CSF or b-estradiol as indicated. FDC-P1 cells were cultured for 1 day in the absence or presence of either IL-3 or b-estradiol as indicated. Proliferation was estimated by the incorporation of [ 3 H]thymidine (6.7 Ci/ mmol, NEN, Boston, MA, USA) which was added during the last 4 ± 6 h of culture as described (McKearn et al., 1985; McCubrey et al., 1989 McCubrey et al., , 1993 .
Retroviral infection of cells
Cells were infected with a retrovirus (pBabepuro3) (Morgenstern et al., 1990 ) encoding a fusion protein (DMEK1:ER) between a constitutively-activated form of MEK1 (DN3-S218E-S222D) and the hormone-binding domain of the human estrogen-receptor (hbER) as described previously for Raf-1 (Mansour et al., 1994; Samuels et al., 1993; Pritchard et al., 1995; Bosch et al., 1997; Aziz et al., 1999) . This retrovirus also encodes resistance to the antibiotic puromycin (puro r ). Plasmid DNAs containing recombinant retroviruses were transfected into the retroviral packaging cell lines PA317 and j2 using lipofectin (Life Technologies, Bethesda, MD, USA). Retroviruses were passed sequentially from one cell line to the other to amplify their titers as described previously (McCubrey et al., 1993) . Puro r PA317 and j2 cells were isolated by selection in DMEM+BCS and 2 mg/ml puromycin (Sigma). Puromycin-resistant (puro r ) TF-1 cells were isolated by selection in 2 mg/ml puromycin in the presence of either GM-CSF or b-estradiol. Puro r FDC-P1 cells were isolated by selection in 1 mg/ml puromycin in the presence of either IL-3 or b-estradiol. Puro r FL5.12 cells were isolated by selection in 2 mg/ml puromycin in the presence of either IL-3 or b-estradiol. The nomenclature of the TF-1, FDC-P1 or FL5.12 cells is TF/DMEK1:ER, FD/DMEK1:ER or FL/DMEK1:ER for cells infected with the DMEK1:ER virus. (GM) indicates that the TF-1 cells were selected in GM-CSF, (IL3) indicates that the FDC-P1 or FL5.12 cells were selected in IL-3, and (Est) indicates that the TF-1, FDC-P1 or FL5.12 cells were selected in b-estradiol. These symbols are followed by either (pool) for a pool of cells or (c) for a clone.
Preparation of cell extracts and analysis by Western blotting
Cells were washed twice with cold phosphate-buered saline (PBS) containing 5 mM Na 2 EDTA and lysed on ice in Gold lysis buer (GLB) containing 20 mM Tris (pH 7.5), 137 mM NaCl, 5 mM Na 2 EDTA, 1% (v/v) Triton X-100, 15% (v/v) glycerol, 1 mM phenylmethylsulfonyl¯uoride, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mM sodium orthovanadate, 1 mM ethylene glycol-bis (b-aminoethyl ether)-N,N,N',N'tetraacetic acid (EGTA), 10 mM sodium¯uoride, 1 mM tetrasodium PP i , and 100 mM b-glycerophosphate. Insoluble material was removed by centrifugation at 15 0006g as described (Samuels et al., 1993; Pritchard et al., 1995; Bosch et al., 1997; McCubrey et al., 1998; Aziz et al., 1999) . Protein lysates used to determine ERK2 activation were prepared as described previously (Samuels et al., 1993; Pritchard et al., 1995; Bosch et al., 1997; McCubrey et al., 1998; Aziz et al., 1999) . All chemicals were purchased from Sigma unless otherwise indicated. The protein concentration of the soluble material was estimated as described previously (Samuels et al., 1993; Pritchard et al., 1995; Bosch et al., 1997; McCubrey et al., 1998; Aziz et al., 1999) . Cellular proteins were analysed by electrophoresis through polyacrylamide gels followed by Western immunoblotting onto polyvinylidene di¯uoride (PVDF) membranes (Immunobilon P; Millipore, New Bedford, MA, USA). Western blots were blocked in 1% bovine serum albumin (BSA) and were then incubated with a-hbER primary antibody (Santa Cruz Biotechnology (SCB), Santa Cruz, CA, USA) at a dilution of 1 : 1000. The blots were washed in Tris-buered saline containing 0.5% (v/v) Tween-20. Antigen-antibody complexes were visualized by using 1 : 10 000-diluted protein A coupled to horseradish peroxidase as described and the enhanced chemiluminescence detection system (Amersham) as described (Samuels et al., 1993; Pritchard et al., 1995; Bosch et al., 1997; McCubrey et al., 1998; Aziz et al., 1999) . The blots were exposed to Kodak XAR5 X-ray ®lm (Rochester, NY, USA). Western blots werè stripped' for reprobing with other primary antibodies by incubation for 2 h at 688C in a buer containing 0.2 M glycine (pH 2.5) and 1% (wt/vol) sodium dodecyl sulfate (SDS).
Determination of MEK1 activity
Lysates were prepared from cells cultured in phenol-red free DMEM or RPMI medium (Life Technologies or Sigma, respectively) containing charcoal-stripped BCS as described above. Some cells were treated with b-estradiol and in certain cases also with PD98059. The WEHI-3B supernatant used in these studies (as a source of IL-3) was prepared from cells grown in phenol red-free DMEM medium containing charcoal-stripped BCS. MEK activity was measured by immunoprecipitating 100 mg of total protein lysate overnight with an aER Ab or aMEK1 Ab and protein A-sepharose beads. The immunoprecipated DMEK1:ER was washed and then used in an in vitro kinase-reaction for 30 min at 308C in a reaction mix containing 100 mM HEPES pH 7.4, 25 mM MgCl 2 , 1 mM DTT, 50 mM ATP, 1 ml [g-32 P]ATP (NEN, 3000 Ci/mMole) and 2 mg of bacterially expressed rp44, an enzymatically-inactive form of MAP kinase (ERK1). The reactions were stopped by adding 7.5 ml of protein sample buer and boiling for 3 min. The reaction mixtures were electrophoresed through a 10% polyacrylamide gel, transferred to PVDF and exposed to X-ray ®lm.
Determination of MAP kinase activity
Cells were deprived of either cytokine or b-estradiol for 18 ± 24 h in phenol-red free medium that contained 5% charcoalstripped BCS. The cells were then pulsed with cytokine, bestradiol or the positive control, 20 nM PMA for varying periods of time. ERK2 activity was determined using an in vitro kinase assay. An aERK2 Ab (SCB) and protein Asepharose beads were used to immunoprecipitate the ERK2 protein overnight from 100 mg of total protein lysate. The immunoprecipitates were washed and then used in a kinase reaction containing 43 mM HEPES pH 7.4, 43 mM MgCl 2 , 200 mM ATP, 0.5 mM DTT, 1 mM [g-32 P]ATP and 2.3 mg myelin basic protein (MBP, Life Technologies) as a substrate. The reactions were carried out at 308C for 30 min before being stopped with 7.5 ml of sample buer. The reaction mixtures were electrophoresed through a 14% polyacrylamide gel, transferred to PVDF and exposed to X-ray ®lm.
Polymerase chain reaction amplification of cytokine mRNA transcripts
Total cytoplasmic RNA was prepared as described (McCubrey et al. 1993 and 1 mg was included in a 20 ml cDNA synthesis reaction containing: reverse transcriptase buer, 1 mM of each dNTP, 20 mg/ml oligo-dT and 20 units Mo-MuLV reverse transcriptase. After incubation at 428C for 40 min, the reaction was terminated by addition of H 2 O. For PCR ampli®cation, 5 ml cDNA was included in a 50 ml reaction mixture containing PCR buer, dNTP, 1 ± 2 units Taq polymerase and 1 mM of each oligonucleotide primer. The primers for murine IL-3 were: AATCAGTGGCCGG-GATACCC and CGAAATCATCCAGATCTCG de®ning a 200 bp cDNA fragment which could readily be distinguished from a genomic IL-3 DNA fragment by size (41 kB). The primers for murine GM-CSF were: CCTGAGGAG-GATGTGGCTGC and CTGTCCAAGCTGAGTCAGCG de®ning a 601 bp fragment. The primers for murine b 2 -microglobulin were TTCTCTCACTGACCGGCCTG and CAGTAGACGGTCTTGGGCTC de®ning a 308 bp fragment. The primers for human GM-CSF were: CCTGGACTGGCTCCCAGCAG and GATGTGGCTGCA-GAGCCTGC de®ning a 425 bp fragment. The primers for human b-actin were: GAGAAGAGCTATGAGCTGCCT and TTCTGCATCCTGTCAGCAATG de®ning a 236 bp fragment.
The primers for human IL-3 were CTCCTGCCGATCCAAACATGAG and AGAGGTTTCA-GAAGTTCTGCTG de®ning a 575 bp fragment. Thirty-®ve cycles of PCR were performed to detect the cDNAs. The PCR products were electrophoresed on 1% agarose gels and visualized after ethidium bromide staining of the gel. Bands that were the expected size were veri®ed by performing Southern hybridization using the appropriate full-length cDNA probe.
